CI

At a glance

ClinicalIndex Comparison Record
Phase 2Unknown· 74 enrolled
Drug / intervention
Oxygen Therapy +5 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02357134
NCT02357134Phase 2Unknown
CompareCT.gov

High-Flow Oxygen for Exertional Dyspnea in Cancer Patients

M.D. Anderson Cancer Center·interventional·Posted Feb 6, 2015·Updated Dec 7, 2022

In Brief

A Phase 2 clinical trial evaluating Oxygen Therapy, Quality-of-Life Assessment, and 2 other interventions for Dyspnea and Malignant Neoplasm. Targeting 74 participants across 1 site.

Detailed Summary

This randomized phase II trial studies how well high-flow oxygen works in reducing difficulty breathing during exercise (exertional dyspnea) in patients with cancer. Dyspnea is linked to decreased lung function, quality of life, and survival. High-flow oxygen is a device that delivers heated and humidified oxygen through the nose. This may be effective in reducing dyspnea, and may help patients' lungs function better and improve their quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyspnea, Malignant Neoplasm
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2UnknownOverdue
201520162017201820192020202120222023202420252026
First PostedFeb 6, 2015
Enrollment StartMar 17, 2015
Primary CompletionDec 30, 2020
Study CompletionMay 31, 2023
TodayJul 1, 2026
Enrollment to primary: 5.8 yearsPosted 11.4 years ago

Interventions

Oxygen Therapyprocedure

Receive high-flow oxygen

Oxygen Therapyprocedure

Receive high-flow air

Quality-of-Life Assessmentother

Ancillary studies

Questionnaire Administrationother

Ancillary studies

Respiratory Therapyprocedure

Receive low-flow oxygen

Respiratory Therapyprocedure

Receive low-flow air